OLR1 and stroke disorder: Current studies on sLOX-1 and other molecules as potential prognostic markers do not consider the patient's history of stroke (or not mentioned) [9–11, 17] or may have already excluded patients with a history of stroke upon enrollment [12, 16, 19].